ABCG2/BCRP decreases the transfer of a food-born chemical carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) in perfused term human placenta.
暂无分享,去创建一个
Jaana Rysä | J. Rysä | P. Myllynen | K. Vähäkangas | M. Ilves | E. Immonen | Päivi Myllynen | Mika Ilves | Maria Kummu | Tiina Kangas | Elina Immonen | Rauna Pirilä | Anni Lastumäki | Kirsi H Vähäkangas | M. Kummu | T. Kangas | Rauna Pirilä | Anni Lastumäki | Elina Immonen
[1] J. Hitti,et al. P-glycoprotein and breast cancer resistance protein expression in human placentae of various gestational ages. , 2005, American journal of physiology. Regulatory, integrative and comparative physiology.
[2] T. Ishikawa,et al. Functional evaluation of ABCB1 (P-glycoprotein) polymorphisms: high-speed screening and structure-activity relationship analyses. , 2004, Drug metabolism and pharmacokinetics.
[3] O. Vuolteenaho,et al. Gene Structure of a New Cardiac Peptide Hormone: A Model for Heart-Specific Gene Expression1. , 2000, Endocrinology.
[4] J. Unadkat,et al. Breast Cancer Resistance Protein 1 Limits Fetal Distribution of Nitrofurantoin in the Pregnant Mouse , 2007, Drug Metabolism and Disposition.
[5] J. Cerhan,et al. Well-done meat intake and the risk of breast cancer. , 1998, Journal of the National Cancer Institute.
[6] K. Turteltaub,et al. The identification of [2-(14)C]2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine metabolites in humans. , 1999, Carcinogenesis.
[7] D. Barker,et al. Developmental origins of adult disease , 2007 .
[8] J. Schellens,et al. Role of breast cancer resistance protein in the bioavailability and fetal penetration of topotecan. , 2000, Journal of the National Cancer Institute.
[9] Jos H Beijnen,et al. The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine. , 2003, Cancer research.
[10] P. Myllynen,et al. The fate and effects of xenobiotics in human placenta , 2007, Expert opinion on drug metabolism & toxicology.
[11] M. S. Miller. Transplacental lung carcinogenesis: molecular mechanisms and pathogenesis. , 2004, Toxicology and applied pharmacology.
[12] A. V. Van Gennip,et al. Mrp2-deficiency in the rat impairs biliary and intestinal excretion and influences metabolism and disposition of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo. , 2001, Carcinogenesis.
[13] P. Kaufmann,et al. Variable expression of P-glycoprotein in the human placenta and its association with mutations of the multidrug resistance 1 gene (MDR1, ABCB1). , 2004, Pharmacogenetics.
[14] S. Ozanne,et al. Mechanisms of Disease: the developmental origins of disease and the role of the epigenotype , 2007, Nature Clinical Practice Endocrinology &Metabolism.
[15] O. van Tellingen,et al. Absence or pharmacological blocking of placental P-glycoprotein profoundly increases fetal drug exposure. , 1999, The Journal of clinical investigation.
[16] H. Autrup. Genetic polymorphisms in human xenobiotica metabolizing enzymes as susceptibility factors in toxic response. , 2000, Mutation research.
[17] P. Myllynen,et al. An examination of whether human placental perfusion allows accurate prediction of placental drug transport: studies with diazepam. , 2002, Journal of pharmacological and toxicological methods.
[18] M Kulldorff,et al. 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine, a carcinogen in high-temperature-cooked meat, and breast cancer risk. , 2000, Journal of the National Cancer Institute.
[19] P. Strickland,et al. Metabolism of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by human cytochrome P4501A1, P4501A2 and P4501B1. , 1998, Carcinogenesis.
[20] V. Ling,et al. P‐glycoprotein stability is affected by serum deprivation and high cell density in multidrug‐resistant cells , 1995, Journal of cellular physiology.
[21] T. Sugimura,et al. Increased risk of mammary carcinoma development following transplacental and trans-breast milk exposure to a food-derived carcinogen, 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP), in Sprague-Dawley rats. , 1995, Cancer research.
[22] O Pelkonen,et al. Carbamazepine and Its Metabolites in Human Perfused Placenta and in Maternal and Cord Blood , 1995, Epilepsia.
[23] B. Sarkadi,et al. Differential Modulation of the Human Liver Conjugate Transporters MRP2 and MRP3 by Bile Acids and Organic Anions* , 2003, Journal of Biological Chemistry.
[24] K. Audus,et al. Controlling drug delivery across the placenta. , 1999, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[25] S. Coburn,et al. Human placental vitamin B6 (pyridoxal) transport: normal characteristics and effects of ethanol. , 1992, The American journal of physiology.
[26] P. Myllynen,et al. Transplacental passage of lamotrigine in a human placental perfusion system in vitro and in maternal and cord blood in vivo , 2003, European Journal of Clinical Pharmacology.
[27] M. Colvin,et al. Impact of environmental exposures on the mutagenicity/carcinogenicity of heterocyclic amines. , 2003, Toxicology.
[28] T. Litman,et al. Acquired mutations in the MXR/BCRP/ABCP gene alter substrate specificity in MXR/BCRP/ABCP-overexpressing cells. , 2001, Cancer research.
[29] K. Iseki,et al. Effects of sex hormones on regulation of ABCG2 expression in the placental cell line BeWo. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.
[30] C. Lowik,et al. Removal of serum factors by charcoal treatment promotes adipogenesis via a MAPK-dependent pathway , 2005, Molecular and Cellular Biochemistry.
[31] G R Lankas,et al. Placental P-glycoprotein deficiency enhances susceptibility to chemically induced birth defects in mice. , 1998, Reproductive toxicology.
[32] W. T. Beck,et al. Identification of a Novel Estrogen Response Element in the Breast Cancer Resistance Protein (ABCG2) Gene , 2004, Cancer Research.
[33] F. Hatch,et al. The isolation and identification of a new mutagen from fried ground beef: 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP). , 1986, Carcinogenesis.
[34] T. Walle,et al. Transport of the cooked-food mutagen 2-amino-1-methyl-6-phenylimidazo-[4,5-b]pyridine (PhIP) across the human intestinal Caco-2 cell monolayer: role of efflux pumps. , 1999, Carcinogenesis.
[35] S. Brennecke,et al. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[36] I. Schoots,et al. Increased bioavailability of the food-derived carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine in MRP2-deficient rats. , 2001, Molecular pharmacology.
[37] L. Hilakivi-Clarke,et al. Fetal origins of breast cancer , 2006, Trends in Endocrinology & Metabolism.
[38] U. Kalyoncu,et al. The breast cancer resistance protein: gatekeeper to the synovium? , 2010 .
[39] J. Kigawa,et al. Expression of P-glycoprotein in human placenta: relation to genetic polymorphism of the multidrug resistance (MDR)-1 gene. , 2001, The Journal of pharmacology and experimental therapeutics.
[40] L. Vaskivuo,et al. DNA damage caused by benzo(a)pyrene in MCF-7 cells is increased by verapamil, probenecid and PSC833. , 2007, Toxicology letters.
[41] Jos H Beijnen,et al. Multidrug resistance protein 2 (MRP2) transports HIV protease inhibitors, and transport can be enhanced by other drugs , 2002, AIDS.
[42] P. Pávek,et al. P-glycoprotein in the placenta: expression, localization, regulation and function. , 2006, Reproductive toxicology.
[43] C. Klaassen,et al. Regulation of hepatic transporters by xenobiotic receptors. , 2005, Current drug metabolism.
[44] J. Keelan,et al. The xenobiotic transporter ABCG2 plays a novel role in differentiation of trophoblast-like BeWo cells. , 2007, Placenta.
[45] A. Bhattacharyya,et al. Variable expression of P-glycoprotein in normal, inflamed, and dysplastic areas in ulcerative colitis , 1992, Diseases of the colon and rectum.
[46] L. Sarkozi,et al. A new recycling technique for human placental cotyledon perfusion: application to studies of the fetomaternal transfer of glucose, inulin, and antipyrine. , 1983, American journal of obstetrics and gynecology.
[47] L. Bennett,et al. PhIP carcinogenicity in breast cancer: computational and experimental evidence for competitive interactions with human estrogen receptor. , 2005, Chemical research in toxicology.
[48] J. Kingdom,et al. Expression of breast cancer resistance protein (BCRP/ABCG2) in human placenta throughout gestation and at term before and after labor. , 2006, Canadian journal of physiology and pharmacology.
[49] E. Snyderwine,et al. DNA adducts of heterocyclic amine food mutagens: implications for mutagenesis and carcinogenesis. , 1999, Carcinogenesis.
[50] M. Oshimura,et al. FUNCTIONAL ASSESSMENT OF ABCG2 (BCRP) GENE POLYMORPHISMS TO PROTEIN EXPRESSION IN HUMAN PLACENTA , 2005, Drug Metabolism and Disposition.
[51] Kirsi Vähäkangas,et al. Gene transfer to human placenta ex vivo: a novel application of dual perfusion of human placental cotyledon. , 2002, American journal of obstetrics and gynecology.
[52] Y. Sugimoto,et al. Estrogen-mediated post transcriptional down-regulation of breast cancer resistance protein/ABCG2. , 2005, Cancer research.
[53] J. Keelan,et al. Active transport across the human placenta: impact on drug efficacy and toxicity , 2006, Expert opinion on drug metabolism & toxicology.
[54] Alfred H. Schinkel,et al. Human Breast Cancer Resistance Protein: Interactions with Steroid Drugs, Hormones, the Dietary Carcinogen 2-Amino-1-methyl-6-phenylimidazo(4,5-b)pyridine, and Transport of Cimetidine , 2005, Journal of Pharmacology and Experimental Therapeutics.
[55] J. Kingdom,et al. Expression of the multidrug resistance P-glycoprotein, (ABCB1 glycoprotein) in the human placenta decreases with advancing gestation. , 2006, Placenta.
[56] N. Illsley,et al. Effects of chronic hypoxia in vivo on the expression of human placental glucose transporters. , 2006, Placenta.
[57] T. Sugimura,et al. Heterocyclic amines: Mutagens/carcinogens produced during cooking of meat and fish , 2004, Cancer science.
[58] Yuichi Sugiyama,et al. Transporters as a determinant of drug clearance and tissue distribution. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[59] Kari Laine,et al. Functional role of P‐glycoprotein in the human blood‐placental barrier , 2005, Clinical pharmacology and therapeutics.
[60] A. Karlsson,et al. Transfer of the food mutagen PhIP to foetuses and newborn mice following maternal exposure. , 1994, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[61] J. Keelan,et al. Drug Transfer and Metabolism by the Human Placenta , 2004, Clinical pharmacokinetics.
[62] P. Strickland,et al. Metabolism of 2-amino-1-methyl-6-phenylimidazo [ 4 , 5b ] pyridine by human cytochrome P 4501 A 1 , P 4501 A 2 and P 4501 B 1 , 1998 .
[63] P. Sivonen,et al. Comparison of the formation of benzo[a]pyrene diolepoxide-DNA adducts in vitro by rat and human microsomes: evidence for the involvement of P-450IA1 and P-450IA2. , 1989, Journal of biochemical toxicology.
[64] Yi Zhang,et al. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells. , 2006, American journal of physiology. Endocrinology and metabolism.
[65] O. Vuolteenaho,et al. Gene Structure of a New Cardiac Peptide Hormone : A Model for Heart-Specific Gene Expression * , 2000 .
[66] L. Joss-Moore,et al. The developmental origins of adult disease , 2009, Current opinion in pediatrics.